Skip to content
Peptigraph home
Shop Peptides50% off*

Is AOD-9604 Legal? FDA, Compounding and WADA Status

AOD-9604's FDA status, compounding rules and anti-doping status, with a dated timeline of every change we track.

Medical review pendingHGH fragment analogUpdated
FDA status
Not approved
research chemical
PCAC vote
Not reviewed
not on the Jul 2026 PCAC agenda
WADA
Prohibited (S2.2.3)
In and out of competition
Not legal adviceStatus reflects public FDA and WADA records on the date shown. Rules differ by country and state.

Current status

Not FDA approved · research chemical

No. AOD-9604 is not FDA approved for any use.

AOD-9604: regulatory status by country
CountryStatusSource
United StatesNo approved product foundNo FDA-approved product found: Drugs@FDA (openFDA) search for active ingredient "aod-9604" returned no matches on 2 Oct 2026.api.fda.govchecked 2 Oct 2026

Timeline

No FDA, advisory-committee or WADA action specific to AOD-9604 found in our records (checked 2 Oct 2026).
Every peptide on the FDA tracker

Compounding and research-use sellers

  • Category 2 is the FDA's list of bulk substances it flagged as raising significant safety concerns. Compounding pharmacies are not expected to compound from them while they are on it.
  • The Pharmacy Compounding Advisory Committee (PCAC) advises the FDA on which substances belong on the 503A bulks list that pharmacies may compound from. Its votes are advice; the FDA decides.
  • "Research use only" products are sold outside these rules and are not checked by the FDA for identity, purity or dose.

FDA compounding record: AOD-9604 appears in FDA's table of bulk drug substances previously in category 2 and withdrawn by the nominators. · fda.gov, checked 2 Oct 2026

Sport and drug testing

Prohibited by WADA (S2.2.3)

AOD-9604 is named as a growth hormone fragment in S2.2.3, prohibited at all times.

Outside the US

Rules differ by country. What each regulator's own records show, with the date we checked:

AOD-9604: regulatory status by country
CountryStatusSource
United KingdomNo approved product foundNo approved product found in an emc (UK SmPC compendium) search for "aod-9604" on 2 Oct 2026.medicines.org.ukchecked 2 Oct 2026
CanadaNo approved product foundNo product found in a Health Canada Drug Product Database search for ingredient "aod-9604" on 2 Oct 2026.health-products.canada.cachecked 2 Oct 2026
European UnionNo centrally authorised EU medicine foundEMA medicines list, searched 2 Oct 2026ema.europa.euchecked 2 Oct 2026

What regulators' own records return for AOD-9604

The US Drugs@FDA lookup for AOD-9604 as an active ingredient returned a not-found error, so no approved product appears in that database.[2]

The UK Electronic Medicines Compendium search for AOD-9604 on the same date returned no results.[4]

Health Canada's drug product database returned zero active-ingredient records for AOD-9604.[5]

FDA's compounding safety notes

FDA's table of bulk drug substances flags AOD-9604 for possible immunogenicity and for peptide-impurity and characterization problems when compounded.[3]

The same entry says FDA identified serious adverse events that may be associated with AOD-9604, with causality unclear.[3]

Sport: the prohibited list

The WADA Prohibited List names AOD-9604 as a growth hormone fragment, a class banned at all times.[1]

Common questions

Is AOD-9604 FDA approved?

No approved product appears: the Drugs@FDA query for the ingredient came back with no matches.[2]

Is AOD-9604 legal to buy?

It is not an approved drug. Online sellers label it "for research use only, not for human use"; the FDA sent warning letters to five such sellers on 24 Aug 2026. Whether a pharmacy may compound it depends on its FDA bulk-substance status. Rules differ by country.

Is AOD-9604 banned by WADA?

Yes. Prohibited by WADA (S2.2.3), in and out of competition.

Is there an official AOD-9604 dosing schedule?

With no approved product in the US, UK or Canada records checked on 2 October 2026, there is no regulator-issued dosing schedule to cite.

Calculated from drugs fda matches 0; emc results 0; health canada records 0; date 2026-10-02. Formula: approved products found in the 3 databases = 0 + 0 + 0 = 0

More on AOD-9604

DosageDoses used in published studies, with the source for each.CalculatorVial, water and dose to syringe units.Side effectsWhat labels and studies report, and what is unknown.ResultsStudy outcomes and when they were measured.BenefitsClaimed benefits next to what published studies measured.How it worksTarget, mechanism and how long it acts, from the label or studies.

Sources

  1. 1World Anti-Doping Code International Standard Prohibited List 2026World Anti-Doping Agency · 2026wada-ama.orgAccessed 2 Oct 2026
  2. 2United States: No FDA-approved product found: Drugs@FDA (openFDA) search for active ingredient "aod-9604" returned no matches on 2 Oct 2026.U.S. Food and Drug Administration · 2026api.fda.govAccessed 2 Oct 2026
  3. 3US compounding: AOD-9604 appears in FDA's table of bulk drug substances previously in category 2 and withdrawn by the nominators.U.S. Food and Drug Administration · 2026fda.govAccessed 2 Oct 2026
  4. 4United Kingdom: No approved product found in an emc (UK SmPC compendium) search for "aod-9604" on 2 Oct 2026.Electronic Medicines Compendium (UK) · 2026medicines.org.ukAccessed 2 Oct 2026
  5. 5Canada: No product found in a Health Canada Drug Product Database search for ingredient "aod-9604" on 2 Oct 2026.Health Canada · 2026health-products.canada.caAccessed 2 Oct 2026
  6. 6EMA medicines export (centrally authorised medicines) (searched 2 Oct 2026)European Medicines Agency · 2026ema.europa.euAccessed 2 Oct 2026

Found an error? Report a correction.